-
Gilead Sciences, Inc. (GILD) Leerink Partners Global Biopharma Conference (Transcript)
13 Mar 2024 01:08 GMT
Gilead Sciences, Inc. (NASDAQ:GILD) Leerink Partners … you said in the last earnings call that you haven…
-
Gold Gains 1%; Walgreens Narrows Earnings Forecast
28 Mar 2024 16:58 GMT
… Aviation: It Has 'No Earnings Power'
Leading and Lagging … better than expected second-quarter earnings and tightened FY24 guidance.
Walgreens … an exclusive license agreement with Gilead Sciences for a tumor-activated IL …
-
6 Gold Standard Dividend Stocks Passive Income Investors Need to Buy
17 Apr 2024 13:29 GMT
… 40 markets, which could drive earnings in the future. Most on … Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. (NASDAQ: GILD) to jointly …
-
ClearBridge Sustainability Leaders Strategy Q1 2024 Portfolio Manager Commentary
17 Apr 2024 11:54 GMT
… to perform well, delivering earnings ahead of expectations and benefiting … significantly. Our outlook for corporate earnings is likewise constructive, which … NKE), SolarEdge Technologies (SEDG) and Gilead Sciences (GILD). ESG Investment: AI Sustainability …
-
Why Is Gilead Sciences Stock Trading Lower Today?
16 Feb 2024 18:32 GMT
Gilead Sciences Inc GILD said it paused … this month, Gilead reported weak earnings results and issued soft guidance …
-
Gilead Sciences to acquire clinical─stage biopharma company, CymaBay Therapeutics for $4.3 billion
14 Feb 2024 04:46 GMT
Gilead Sciences, Inc. and CymaBay Therapeutics, … chairman and chief executive officer, Gilead Sciences. “Building on the strong … be approximately neutral to earnings per share in 2025 … have high unmet medical need.
Gilead Sciences, Inc. is a biopharmaceutical …
-
Gilead Sciences to acquire CymaBay Therapeutics for USD 4.3 billion
13 Feb 2024 10:03 GMT
Foster City: Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. … , Chairman and Chief Executive Officer, Gilead Sciences. “Building on the strong research … will be approximately neutral to earnings per share in 2025 and …
-
Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
12 Feb 2024 13:36 GMT
… will be approximately neutral to earnings per share in 2025 … (formerly Twitter) and LinkedIn.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company … X/Twitter (@Gilead Sciences) and LinkedIN (@Gilead-Sciences).
View source version on …
-
Gilead Sciences, Inc. to Post FY2028 Earnings of $8.73 Per Share, Leerink Partnrs Forecasts (NASDAQ:GILD)
09 Feb 2024 09:44 GMT
… issued their FY2028 earnings per share (EPS) estimates for Gilead Sciences in a … for Gilead Sciences’ current full-year earnings is $7.35 per share.
Gilead Sciences (NASDAQ … :GILD – Get Free Report) last issued its quarterly earnings …
-
Gilead Sciences (NASDAQ:GILD) Given New $84.00 Price Target at Wells Fargo & Company
08 Feb 2024 13:41 GMT
… .
Get Our Latest Analysis on Gilead Sciences
Gilead Sciences Stock Down 4.2 % … .25.
Gilead Sciences (NASDAQ:GILD – Get Free Report) last issued its earnings results … . Analysts forecast that Gilead Sciences will post 7.35 earnings per share for …